| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |